Armata Pharmaceuticals Inc (ARMP)
2.56
+0.01
(+0.39%)
USD |
NYAM |
May 01, 11:31
Armata Pharmaceuticals Free Cash Flow (Quarterly): -10.51M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -10.51M |
| September 30, 2023 | -13.20M |
| June 30, 2023 | -12.28M |
| March 31, 2023 | -19.58M |
| December 31, 2022 | -10.03M |
| September 30, 2022 | -11.63M |
| June 30, 2022 | -9.284M |
| March 31, 2022 | -3.751M |
| December 31, 2021 | -8.826M |
| September 30, 2021 | -5.546M |
| June 30, 2021 | -4.734M |
| March 31, 2021 | -5.773M |
| December 31, 2020 | -6.668M |
| September 30, 2020 | -3.961M |
| June 30, 2020 | -4.129M |
| March 31, 2020 | -4.336M |
| December 31, 2019 | -2.75M |
| September 30, 2019 | -4.502M |
| June 30, 2019 | -5.953M |
| March 31, 2019 | -2.601M |
| December 31, 2018 | -1.51M |
| September 30, 2018 | -2.176M |
| June 30, 2018 | -2.204M |
| March 31, 2018 | -3.536M |
| December 31, 2017 | -2.387M |
| Date | Value |
|---|---|
| September 30, 2017 | -0.626M |
| June 30, 2017 | -2.933M |
| March 31, 2017 | -3.304M |
| December 31, 2016 | -1.511M |
| September 30, 2016 | -3.16M |
| June 30, 2016 | -3.017M |
| March 31, 2016 | -3.197M |
| December 31, 2015 | -2.367M |
| September 30, 2015 | -2.613M |
| June 30, 2015 | -2.671M |
| March 31, 2015 | -2.34M |
| December 31, 2014 | -3.205M |
| September 30, 2014 | -2.764M |
| June 30, 2014 | -3.885M |
| March 31, 2014 | -3.92M |
| December 31, 2013 | -1.417M |
| September 30, 2013 | -2.526M |
| June 30, 2013 | -1.332M |
| March 31, 2013 | -1.119M |
| September 30, 2009 | 1.247M |
| June 30, 2009 | -1.447M |
| March 31, 2009 | -1.30M |
| December 31, 2008 | -3.967M |
| September 30, 2008 | -3.336M |
| June 30, 2008 | -0.161M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-19.58M
Minimum
Mar 2023
-2.75M
Maximum
Dec 2019
-7.760M
Average
-5.953M
Median
Jun 2019
Free Cash Flow (Quarterly) Benchmarks
| AIM ImmunoTech Inc | -9.956M |
| Perspective Therapeutics Inc | -9.097M |
| Protalix BioTherapeutics Inc | 3.345M |
| Electromed Inc | 3.384M |
| Xtant Medical Holdings Inc | -1.278M |